Fierce Fight Between Sinopharm And Shanghai Pharma On H Share Market
This article was originally published in PharmAsia News
Executive Summary
The fight between China's two largest state-owned drug producers, Sinopharm and Shanghai Pharmaceutical, drew to a close on the H share market as of May 12